P&G Health Declares ₹160 Interim Dividend with February 12 Record Date
Procter & Gamble Health Limited's Board approved interim dividend of ₹160 per equity share for FY 2025-26, including a special dividend component of ₹50 per share. The company provided detailed TDS guidelines with varying rates for different shareholder categories and set February 10, 2026 as the deadline for document submission to avail appropriate tax rates.
*this image is generated using AI for illustrative purposes only.
Procter & Gamble Health Limited has declared an interim dividend of ₹160 per equity share, including a one-time special dividend of ₹50 per share, for Financial Year 2025-26. The Board of Directors approved this dividend declaration at their meeting held on February 6, 2026.
Dividend Declaration Details
The company's interim dividend announcement represents a significant return to shareholders, combining regular dividend payments with a special distribution. The dividend will be payable to eligible shareholders whose names appear in the Register of Members or in the records of Depositories as beneficial owners.
| Parameter: | Details |
|---|---|
| Total Dividend Amount: | ₹160 per equity share |
| Regular Dividend: | ₹110 per share |
| Special Dividend: | ₹50 per share |
| Face Value: | ₹10 per share |
| Record Date: | February 12, 2026 |
| Board Meeting Date: | February 6, 2026 |
Tax Deduction Guidelines
The company has issued comprehensive guidelines regarding Tax Deduction at Source (TDS) on dividend payments, in accordance with the Income Tax Act, 1961 as amended by the Finance Act, 2020. Since April 1, 2020, dividends are taxable in shareholders' hands, requiring the company to deduct tax at source at applicable rates.
Resident Shareholders TDS Rates
| Shareholder Category: | TDS Rate | Requirements |
|---|---|---|
| Individual (dividend ≤ ₹10,000): | Nil | No documentation required |
| Individual with Form 15G/15H: | Nil | Valid Form 15G or 15H submission |
| PAN Available: | 10% | Updated PAN with depositories/RTA |
| PAN Not Available/Invalid: | 20% | - |
| Insurance Companies: | Nil | IRDAI registration certificate |
| Mutual Funds/Government: | Nil | SEBI registration/documentary evidence |
Non-Resident Shareholders
Non-resident shareholders, including Foreign Institutional Investors (FII) and Foreign Portfolio Investors (FPI), will be subject to 20% TDS plus applicable surcharge and cess, or beneficial DTAA rates if eligible documentation is provided.
Compliance Requirements
Shareholders must submit required forms and documents by February 10, 2026, to avail appropriate TDS rates. The company will not consider incomplete, unsigned, or late submissions. TDS certificates will be emailed to registered email addresses, and shareholders can view TDS credits in Form 26AS through their e-filing accounts.
Shareholder Action Items
Shareholders holding shares in dematerialized mode should update their records with depositories through depository participants, while physical shareholders must provide details to the company's registrar, KFin Technologies Private Limited. Updated bank details are also required for electronic dividend distribution as per SEBI directives.
Historical Stock Returns for Procter & Gamble Health
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.23% | +2.11% | -5.03% | -20.11% | -4.34% | -23.80% |
20
